Platelet-rich plasma injection for poor ovarian response
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether injecting your own platelet-rich plasma (PRP) into the ovaries can improve egg retrieval and embryo development for women who have had very few eggs or no transplantable embryos in previous IVF cycles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman under 45 who has been trying to get pregnant for at least 1 year.
- You are planning IVF treatment at Peking University Third Hospital.
- In a past IVF cycle, you had 3 or fewer eggs retrieved, or no embryos that could be transferred, or had embryo transfer fail 2 or more times.
- Your body mass index (BMI) is between 18.5 and 29.
- You do not have serious blood disorders, autoimmune diseases, or uncontrolled thyroid problems.
- You are not currently taking corticosteroids or antiplatelet drugs like aspirin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting platelet-rich plasma (a concentrate from your own blood) into the uterus or ovaries can help women with certain fertility issues, such as damaged uterine lining, scarring, or low egg reserve. It aims to improve pregnancy chances in these challenging cases.
This trial tests whether injecting a woman's own cells into her ovaries can help improve egg production for women with very low ovarian reserve. It is for women under 45 who have had poor results from IVF in the past.
This study looks at how a treatment called StemCell Regenera, which uses a growth factor medicine (Filgrastim), affects the blood of women with poor ovarian response or low egg reserve. The goal is to understand how the treatment might help reactivate the ovaries.
This trial studies whether an injection of your own “platelet-rich” plasma into the ovaries can improve egg production in people who respond poorly to fertility treatment. It targets women with low egg reserve and tries to see if this approach helps them get better results from stimulation.
This trial tests whether injecting your own platelet-rich plasma (PRP) into the ovaries can improve egg production in people who don’t respond well to fertility stimulation. It may help some “poor responders” get more usable eggs for IVF.
This trial tests whether injecting your own PRP (platelet-rich plasma) into the ovaries can improve ovarian function in some menopausal women. It may help those whose menopause seems less advanced, but not everyone will be eligible based on health and test results.
Hear when a new Poor Ovarian Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.